English
Specials
    Upgrade

    Moneycontrol

    Budget 2023Budget 2023

    PARTNERS

    • Tata AIA Life Insurance
    • Hafele
    • Motilal Oswal
    • SMC Global Securities Limited
    • SBI Life
    • DSP Mutual Fund
    Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now
    you are here: HomeNewsOpinion

    Aurobindo Pharma’s Cronus rethink is positive, but it needs to do more

    Aurobindo Pharma terminated an agreement to acquire a majority stake in Cronus Pharma after the proposal stoked capital allocation concerns

    R. Sree Ram
    August 24, 2021 / 09:30 AM IST
    Aurobindo Pharma’s Cronus rethink is positive, but it needs to do more

    Representative image

    Shares of Aurobindo Pharma gained in Monday trading after it decided to terminate an agreement to acquire a majority stake in Cronus Pharma. The acquisition proposal along with the company's weak June quarter results riled investors. The stock lost a fifth of its value in less than 10 trading days after the announcement of the acquisition. The Rs 420 crore acquisition amounts to less than 8 percent of Aurobindo’s FY21 net earnings and is unlikely to have made a major dent to its finances. However, the...

    • PRO Panorama

      Moneycontrol Pro Panorama | Budget 2023: Bonds jump in joy, stocks sulk

      Feb 3, 2023 / 02:02 PM IST

      In today’s edition of Moneycontrol Pro Panorama: Old Pension Scheme is not a gamechanger, bitcoin makes a comeback, big firms st...

      Read Now

    To read the full story, Subscribe to Moneycontrol PRO

    Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

    View Plans

    Already a member? Sign in

    Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

    50% OFF

    What Do You Get

    • Ad free experience

      Experience a non-intrusive navigation and faster response in the ad free mode

    • Sharpest Opinions

      Access to 230+ exclusive stories per month from our editorial and Experts

    • +

      Have a Global edge with access to content from world renowned experts and journalist

    • Actionable Insights

      Access to 40+ weekly investment ideas including 4 daily technical calls

    • Virtual Events

      Exclusive access to live webinars from market experts on trading and investment strategies

    • Newsletters

      Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

    View Offers

    Get upto 50% discount on limited period offers